REPLIGEN CORPORATION - COMMON STOCK
156.62
01-May-24 13:32:24
15 minutes delayed
Stocks
-7.58
-4.62%
Today's range
151.82 - 164.15
ISIN
N/A
Source
NASDAQ
-
Repligen to Report Third Quarter 2023 Financial Results
17 Oct 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
02 Oct 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
26 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Appoints Jason K. Garland as Chief Financial Officer
12 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Wells Fargo Healthcare Conference
01 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
17 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
02 Aug 2023 06:30:01 By Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2023 Financial Results
19 Jul 2023 06:30:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK
06 Jul 2023 08:48:50 By NetDania Notify
-
NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK
28 Jun 2023 08:45:03 By NetDania Notify
-
NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK
27 Jun 2023 08:53:09 By NetDania Notify
-
Repligen Corporation to Present at Upcoming Investor Conferences
31 May 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
02 May 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2023 Financial Results
18 Apr 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
14 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
22 Feb 2023 06:30:01 By Nasdaq GlobeNewswire
-
Repligen Appoints Martin D. Madaus to Board of Directors
09 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
08 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 06:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
08 Nov 2022 06:30:00 By Nasdaq GlobeNewswire